Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 63001 participants.

Also called NCT03367325

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 63,001 participants (planned count) (from the registry)
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (from the registry)
Registry
  • NCT NCT03367325
Other papers using this trial's data
  • Clinical value of a tool for managing oral anticoagulation in nonvalvular atrial fibrillation in primary health care. Randomized clinical trial Revista espanola de cardiologia (English ed.), 2024-06 DOI, PubMed 38056770

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03367325. Randomized; triple masking; primary purpose prevention. Start 2017-12-15 (actual); primary completion 2019-12-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation
Acronym
NACOs
Condition
Anticoagulants
Condition
Clinical Decision Support Systems
Intervention (Device)
CDS-NVAF
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (class: other)
Collaborator
Institut Català de la Salut (class: other)
Collaborator
Department of Health, Generalitat de Catalunya (class: other government)

Record details

Record id
cardio:ct-nct03367325
Content hash
e130cf6201779bbc06037f2106ce1c0f198894de9edd37ad192db0cf1e963188